miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors
Open Access
- 7 November 2017
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 8 (1) , 249
Abstract
MSC-NTF cells are Mesenchymal Stromal Cells (MSC) induced to express high levels of neurotrophic factors (NTFs) using a culture-medium based approach. MSC-NTF cells have been successfully studied in clinical trials for Amyotrophic Lateral Sclerosis (ALS) patients. MicroRNAs (miRNA) are short non-coding RNA molecules that coordinate post-transcriptional regulation of multiple gene targets. The purpose of this study was to determine whether the miRNA profile could provide a tool for MSC-NTF cell characterization and to distinguish them from the matched MSC from which they are derived. NTF secretion in the culture supernatant of MSC-NTF cells was evaluated by ELISA assays. The Agilent microarray miRNA platform was used for pairwise comparisons of MSC-NTF cells to MSC. The differentially expressed miRNAs and putative mRNA targets were validated using qPCR analyses. Principal component analysis revealed two distinct clusters based on cell type (MSC and MSC-NTFs). Nineteen miRNAs were found to be upregulated and 22 miRNAs were downregulated in MSC-NTF cells relative to the MSC cells of origin. Further validation of differentially expressed miRNAs confirmed that miR-3663 and miR-132 were increased 18.5- and 4.06-fold, respectively while hsa-miR-503 was reduced more than 15-fold, suggesting that miRNAs could form the basis of an MSC-NTF cell characterization assay. In an analysis of the miRNA mRNA targets, three mRNA targets of hsa-miR-132-3p (HN-1, RASA1 and KLH-L11) were found to be significantly downregulated. We have demonstrated that MSC-NTF cells can be distinguished from their MSCs of origin by a unique miRNA expression profile. Clinicaltrial.gov identifier NCT01777646 . Registered 12 December 2012.Keywords
Funding Information
- BrainStorm Cell Therapeutics
This publication has 36 references indexed in Scilit:
- Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autismBehavioural Brain Research, 2017
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?Neurobiology of Disease, 2017
- Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?Neurobiology of Disease, 2017
- Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral SclerosisJAMA Neurology, 2016
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implicationsNature Immunology, 2014
- Safety of repeated transplantations of neurotrophic factors‐secreting human mesenchymal stromal stem cellsClinical and Translational Medicine, 2014
- Mesenchymal Stromal Cells: Sensors and Switchers of InflammationCell Stem Cell, 2013
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Role of neurotrophic factors in neuronal developmentCurrent Opinion in Neurobiology, 1996